regulatory affairs pharma
OUR GOAL IS TO EXCEED YOUR EXPECTATIONS
Regulatory Affairs, Drug Development, Pharmacovigilance, Medical Writing, Pricing Reimbursement, Market Access
Global and Local Regulatory Affairs
Strategic Advice and Due Diligence
Pricing & Reimbursement and Market Access
eCTD and Regulatory Procedures Management
Orphan Drug Applications
Pharmaceutical, Preclinical and Clinical Development
Clinical Trial Applications
Quality Management and Auditing
Scientific / Medical Writing
Product Information and Readability Testing
Life Cycle Management
Biocides, Food Supplements and Cosmetics
Partner of many pharmaceutical companies, managing hundreds of multi-task projects, on a worldwide-scale
Discover next events
NEW LEGISLATION ABOUT COMPASSIONATE USE IN.
The new legislation about “Discipline of the therapeutic use of an investigational medicinal product” (Ministerial Decree Sept.
NEW EUDRAVIGILANCE VERSION: IMPACT ON THE .
On November 22nd, 2017 EMA will launch a new and improved version of EudraVigilance. This will have impact also to the Italian .
REGULATORY PHARMA NET EXHIBITS AT ISPOR 20.
RPN will exhibit at ISPOR 20TH Annual European Congress that will be held at the Scottish Event Campus (SEC), Glasgow, Scotland�.
Some useful links are here available.
Would you like to work with us?
We look forward to receiving your application and meeting you
Our experts are available to help you with any question you might have
Corso Italia, 108 – 56125 Pisa Italy
Phone: +39 050 503 954 / 500 785 – Fax: +39 050 220 4315
VAT number: 02263880482 – Pisa REA business registry: n. 142208 – Corporation stock: € 15.600 i.v.
If you wish to contact us please read the information notice below and then check on the box at the bottom of the contact form. By checking you consent in accordance with Section 23 of Italian PDPA.
This information notice is provided pursuant to Section 13 of the Italian Legislative Decree No. 196/2003, as amended (the “Italian PDPA”) and applies to personal data voluntarily provided by users (“Data Subjects”) who use the “Contact Us” form (“Form”) of the company website www.regulatorypharmanet.com (“Site”).
The Company may process personal data that you provided via the Form for the sole purpose of processing your requests and/or enquiries (including but not limited to, requests for technical assistance and information). Where marked, personal data are necessary for the Company to process your requests and/or enquiries or to contact you to follow up your queries. Refusal to provide data marked will prevent the Company from providing the services you may have requested.
You may at any times exercise the rights established by Section 7 of the Italian PDPA, including your right to receive confirmation of the existence of your personal data within the Company, your right to check the content, the source and the accuracy of your data, and/or to request that your data are updated, erased and/or de-identified, if unlawfully processed, as well as your right to stop the processing of your data for any legitimate reasons. At any times you may apply the Data Controller sending and e-mail to [email protected]
To receive information on the processing of your personal data by the Company, to exercise the rights established by the Italian PDPA, as well as to receive the updated list of subjects to whom data are accessible.
The Data Controller is Regulatory Pharma Net Srl (“Company”), with registered offices in Corso Italia 108, 56125, Pisa, Italy.
Having read the above, you authorize the processing and communication of personal data to Regulatory Pharma Net Srl and the companies related to it.